Oral Fecal Microbiota Transplant Capsules Are Safe and Effective for Recurrent Clostridioides difficile Infection: A Systematic Review and Meta-Analysis

Review (12 case series and 3 RCTs, n=763) found an overall efficacy of 82.1% with a low rate of serious adverse events. Authors conclude that the results are promising and ease of administration and non-invasive delivery are positive features, but further studies are needed.

Source:

Journal of Clinical Gastroenterology